Heinrich Haas
professor
Professor Dr. Heinrich Haas is a leading researcher from the British company NeoVac, co-authoring an influential perspective on the design and stability of lipid nanoparticles, which play a crucial role in the efficacy and safety of future mRNA vaccines.
Global Media Ratings
Dominance
0.00%
Persistence
0 wks
Reach
1,909
Power
51$
Sentiment
7.00
Countries Mentioned
| Country | Mentions | Sentiment | Dominance | + Persistence | x Population | = Reach | x GDP (millions) | = Power |
|---|---|---|---|---|---|---|---|---|
| Slovenia | 1 | 7.00 | 0.09% | +0% | 2,078,938 | 1,909 | $56,000 | 51$ |
| Totals | 1 | 2,078,938 | 1,909 | $56,000 | 51$ |
Interactive World Map
Each country's color is based on "Mentions" from the table above.
Recent Mentions
Slovenia:
Heinrich Haas is a co-author of the article and a professor at NeoVac in the UK.
7